Royce & Associates LP Harmony Biosciences Holdings, Inc. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 78,703 shares of HRMY stock, worth $2.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

78,703

Previous 90,116 12.66%

Holding current value

$2.75 Million

Previous $2.72 Million 15.67%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$30.0 - $39.95 $342,390 - $455,949	-11,413 Reduced 12.66%	78,703 $3.14 Million
Q2 2024 Aug 13, 2024	SELL	$28.81 - $33.01 $233,994 - $268,107	-8,122 Reduced 8.27%	90,116 $2.72 Million
Q1 2024 May 13, 2024	SELL	$29.93 - $35.06 $340,154 - $398,456	-11,365 Reduced 10.37%	98,238 $3.3 Million
Q4 2023 Feb 12, 2024	SELL	$19.2 - $33.78 $3.28 Million - $5.77 Million	-170,746 Reduced 60.9%	109,603 $3.54 Million
Q3 2023 Nov 09, 2023	BUY	$31.89 - $39.03 $1.94 Million - $2.37 Million	60,770 Added 27.68%	280,349 $9.19 Million
Q2 2023 Aug 07, 2023	SELL	$30.5 - $37.4 $3.44 Million - $4.22 Million	-112,750 Reduced 33.93%	219,579 $7.73 Million
Q1 2023 May 04, 2023	BUY	$30.8 - $53.92 $3.14 Million - $5.5 Million	102,059 Added 44.32%	332,329 $10.9 Million
Q4 2022 May 23, 2023	SELL	$45.4 - $60.91 $4.63 Million - $6.22 Million	-102,059 Reduced 30.71%	230,270 $12.7 Million
Q4 2022 Feb 13, 2023	SELL	$45.4 - $60.91 $2.98 Million - $4 Million	-65,740 Reduced 22.21%	230,270 $12.7 Million
Q3 2022 Nov 03, 2022	BUY	$42.06 - $55.45 $1.17 Million - $1.54 Million	27,813 Added 10.37%	296,010 $13.1 Million
Q2 2022 Aug 04, 2022	BUY	$33.54 - $52.15 $415,560 - $646,138	12,390 Added 4.84%	268,197 $13.1 Million
Q1 2022 May 05, 2022	BUY	$33.14 - $51.13 $1.22 Million - $1.88 Million	36,723 Added 16.76%	255,807 $12.4 Million
Q4 2021 Feb 07, 2022	SELL	$34.09 - $43.91 $351,331 - $452,536	-10,306 Reduced 4.49%	219,084 $9.34 Million
Q3 2021 Nov 10, 2021	BUY	$25.68 - $38.61 $2.6 Million - $3.91 Million	101,340 Added 79.14%	229,390 $8.79 Million
Q2 2021 Aug 06, 2021	BUY	$25.96 - $33.44 $3.32 Million - $4.28 Million	128,050 New	128,050 $3.62 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.07B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Harmony Biosciences Holdings, Inc. Transaction History